Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Lions Health Reflections: An Enormous Shift Is On The Way

By Ed Mitzen Strategy, Fingerpaint   During my 16 years owning advertising agencies, I’ve always felt that producing great creative within the healthcare space was like being the best skier in the tropics. The work never garnered any respect among mainstream advertising critics, and the healthcare agencies were always hiding behind regulations: “We can’t do […]

Read More »

Lions Health belts a mighty “meow.” But, not for long.

Five reasons Lions Health could consume Cannes By Susan PerlbachsExecutive Director GSWNY, an inVentiv Health Company     Cannes Lions Health’s tagline is “Life-changing creativity.” Sounds lofty, right? As one often hears in this biz, perhaps an over promise? I have news for you: It’s not. Life-changing creativity is exactly what this show is about. […]

Read More »

Hetlioz pill may ease sleep disorder for some blind people

Hetlioz, a prescription pill designed to help blind people sleep at night and stay awake during the day, helped some achieve normal sleep rhythms in two company-funded studies. Vanda Pharmaceuticals Inc. won U.S. marketing approval for Hetlioz (tasimelteon) last year as a treatment for what’s known as non-24-hour sleep-wake disorder, or “non-24,” a chronic circadian […]

Read More »

High risk medical devices backed by few studies

Many high-risk therapeutic devices get Food and Drug Administration (FDA) approval with only one study proving their safety and efficacy before going to market. Studies of how the devices work once they are on the market are also few and far between, according to a new study that looked at all 28 high-risk devices approved […]

Read More »

Merck & Co. Has Eliminated More Than 85% of Jobs Targeted in Its 2013 Restructuring Plans

Pharmaceutical giant Merck & Co. (MRK) has slashed more than 85 percent of the positions targeted for elimination under its 2013 restructuring plan, Gen News reported this morning.   Merck has eliminated “approximately 7,290 positions” since the restructuring plan was announced, the company said in its 10-Qc filing. The positions include full-time employees, independent contractors […]

Read More »

Bay Area’s Relypsa May Double Workforce by End of Year, Inks Deals With Sanofi and Fresenius

Redwood City, Calif.-based Relypsa Inc. (RLYP) announced yesterday that it had signed a two-year detailing deal with Sanofi for the commercialization of a kidney disease drug. It also announced today an exclusive partnership with St. Gallen, Switzerland-based Vifor Fresenius Medical Care Renal Pharma Ltd. (VFMCRP) for the same drug in Europe and additional territories.   […]

Read More »

Google Is Now Alphabet, And That Could Spell Big Things For Health Care

If you’re searching for reasons why Google has renamed itself Alphabet, here’s one: It positions the tech company to expand into health care, which could be very healthy for its long-term fortunes. Google’s health care ambitions are no secret. In the past year alone, the company has teased a pill that would detect cancer, debuted […]

Read More »

Pharmacy benefit manager CVS urges rewrite for U.S. heart guidelines

CVS Health Corp, the second-largest manager of drug benefit plans for U.S. employers and insurers, asked heart specialists on Monday to revamp guidelines for treating patients with high cholesterol after the launch of new, expensive medications. The unusual move is the latest salvo in the war on escalating U.S. healthcare costs, with insurers using aggressive […]

Read More »

HCB Health Names Joe Doyle Vice President of Digital Strategy

AUSTIN, Texas, August 10, 2015 – HCB Health, one of the nation’s top independent healthcare advertising agencies, today named Joe Doyle as vice president of digital strategy. Doyle will oversee interactive strategy for both of HCB’s offices in Austin and Chicago, and collaborate with his team to develop online solutions including websites, social media campaigns […]

Read More »

Upsher-Smith Receives FDA Approval For Generic Version Of Namenda (Memantine HCl) Tablets

MAPLE GROVE, Minn., Aug. 10, 2015 /PRNewswire/ — Upsher-Smith Laboratories, Inc. (Upsher-Smith) announced that it has received U.S. Food and Drug Administration (FDA) approval of an abbreviated new drug application (ANDA) for Memantine Hydrochloride Tablets in 5 mg and 10 mg strengths. Memantine Hydrochloride Tablets are equivalent to the branded product, Namenda®, which is indicated for […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom